![Thierry Bardon](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Thierry Bardon
Direktor/Vorstandsmitglied bei Aterovax SA
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Isabelle de Baillenx | F | - |
FA Dièse SAS
![]() FA Dièse SAS Investment ManagersFinance FA Dièse SAS is the Paris office of FA Dièse, a French private equity investment firm established in Bordeaux in 2001. The firm started operating in Paris in 2007. The shareholders of FA Dièse include business angels and entrepreneurs, as well as institutions such as banks, insurance companies and regional private equity funds. | 23 Jahre |
Gérald Ulrich | M | - |
Aterovax SA
![]() Aterovax SA Medical/Nursing ServicesHealth Services Aterovax SA develops in vitro diagnostic products for the management and assessment of cardiovascular diseases. Its products include diagnostic blood tests for determining and measuring activity of the cardiovascular biomarkers secretory phospholipase A2 (sPLA2) and secretory phospholipase A2-IIA (sPLA2-IIA) which provide physicians clinical information about the presence of a destabilized atherosclerotic plaque. The company was founded by Alain Tedgui, Ziad Mallat, Philippe Gabriel Steg, Joelle Benessiano and Jean-Marie Freyssinet on June 29, 2006 and is headquartered in Paris, France. | - |
Luc Dohan | M | - |
FA Dièse SAS
![]() FA Dièse SAS Investment ManagersFinance FA Dièse SAS is the Paris office of FA Dièse, a French private equity investment firm established in Bordeaux in 2001. The firm started operating in Paris in 2007. The shareholders of FA Dièse include business angels and entrepreneurs, as well as institutions such as banks, insurance companies and regional private equity funds. | - |
Benoît Pastour | M | 61 |
Aterovax SA
![]() Aterovax SA Medical/Nursing ServicesHealth Services Aterovax SA develops in vitro diagnostic products for the management and assessment of cardiovascular diseases. Its products include diagnostic blood tests for determining and measuring activity of the cardiovascular biomarkers secretory phospholipase A2 (sPLA2) and secretory phospholipase A2-IIA (sPLA2-IIA) which provide physicians clinical information about the presence of a destabilized atherosclerotic plaque. The company was founded by Alain Tedgui, Ziad Mallat, Philippe Gabriel Steg, Joelle Benessiano and Jean-Marie Freyssinet on June 29, 2006 and is headquartered in Paris, France. | 11 Jahre |
Antoine Ferry | M | 64 |
Aterovax SA
![]() Aterovax SA Medical/Nursing ServicesHealth Services Aterovax SA develops in vitro diagnostic products for the management and assessment of cardiovascular diseases. Its products include diagnostic blood tests for determining and measuring activity of the cardiovascular biomarkers secretory phospholipase A2 (sPLA2) and secretory phospholipase A2-IIA (sPLA2-IIA) which provide physicians clinical information about the presence of a destabilized atherosclerotic plaque. The company was founded by Alain Tedgui, Ziad Mallat, Philippe Gabriel Steg, Joelle Benessiano and Jean-Marie Freyssinet on June 29, 2006 and is headquartered in Paris, France. | 17 Jahre |
Eric Viaud | M | 65 |
Aterovax SA
![]() Aterovax SA Medical/Nursing ServicesHealth Services Aterovax SA develops in vitro diagnostic products for the management and assessment of cardiovascular diseases. Its products include diagnostic blood tests for determining and measuring activity of the cardiovascular biomarkers secretory phospholipase A2 (sPLA2) and secretory phospholipase A2-IIA (sPLA2-IIA) which provide physicians clinical information about the presence of a destabilized atherosclerotic plaque. The company was founded by Alain Tedgui, Ziad Mallat, Philippe Gabriel Steg, Joelle Benessiano and Jean-Marie Freyssinet on June 29, 2006 and is headquartered in Paris, France. | 18 Jahre |
Michel Datchary | M | 72 |
FA Dièse SAS
![]() FA Dièse SAS Investment ManagersFinance FA Dièse SAS is the Paris office of FA Dièse, a French private equity investment firm established in Bordeaux in 2001. The firm started operating in Paris in 2007. The shareholders of FA Dièse include business angels and entrepreneurs, as well as institutions such as banks, insurance companies and regional private equity funds. | 10 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Jean-Paul Villot | M | 78 |
FA Dièse SAS
![]() FA Dièse SAS Investment ManagersFinance FA Dièse SAS is the Paris office of FA Dièse, a French private equity investment firm established in Bordeaux in 2001. The firm started operating in Paris in 2007. The shareholders of FA Dièse include business angels and entrepreneurs, as well as institutions such as banks, insurance companies and regional private equity funds. | 6 Jahre |
Jean-Pierre Mollet | M | - |
FA Dièse SAS
![]() FA Dièse SAS Investment ManagersFinance FA Dièse SAS is the Paris office of FA Dièse, a French private equity investment firm established in Bordeaux in 2001. The firm started operating in Paris in 2007. The shareholders of FA Dièse include business angels and entrepreneurs, as well as institutions such as banks, insurance companies and regional private equity funds. | - |
Vladimir Bolze | M | - |
FA Dièse SAS
![]() FA Dièse SAS Investment ManagersFinance FA Dièse SAS is the Paris office of FA Dièse, a French private equity investment firm established in Bordeaux in 2001. The firm started operating in Paris in 2007. The shareholders of FA Dièse include business angels and entrepreneurs, as well as institutions such as banks, insurance companies and regional private equity funds. | 8 Jahre |
Emmanuel Valentin | M | - |
Aterovax SA
![]() Aterovax SA Medical/Nursing ServicesHealth Services Aterovax SA develops in vitro diagnostic products for the management and assessment of cardiovascular diseases. Its products include diagnostic blood tests for determining and measuring activity of the cardiovascular biomarkers secretory phospholipase A2 (sPLA2) and secretory phospholipase A2-IIA (sPLA2-IIA) which provide physicians clinical information about the presence of a destabilized atherosclerotic plaque. The company was founded by Alain Tedgui, Ziad Mallat, Philippe Gabriel Steg, Joelle Benessiano and Jean-Marie Freyssinet on June 29, 2006 and is headquartered in Paris, France. | 9 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Frankreich | 11 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Thierry Bardon
- Persönliches Netzwerk